Table 2 Concomitant treatment with lanthanum carbonate during the study
Use of lanthanum carbonate at baseline | Use of lanthanum carbonate during the study | Total, N = 83 | Bixalomer, n = 43 | Calcium carbonate, n = 40 |
|---|---|---|---|---|
Yes, N = 28 | No or lacking data, n (%) | 8 (28.6) | 6 (40.0) | 2 (15.4) |
Yes, n (%) | 20 (71.4) | 9 (60.0) | 11 (84.6) | |
Mean ± SD | 1023 ± 647 | 1153 ± 796 | 917 ± 511 | |
Median | 750 | 750 | 750 | |
Minimum/maximum | 350/2250 | 429/2250 | 350/1875 | |
No, N = 55 | No or lacking data, n (%) | 35 (63.6) | 16 (57.1) | 19 (70.4) |
Yes, n (%) | 20 (36.4) | 12 (42.9) | 8 (29.6) | |
Mean ± SD | 864 ± 522 | 831 ± 637 | 914 ± 311 | |
Median | 750 | 750 | 781 | |
Minimum/maximum | 250/2250 | 250/2250 | 500/1375 |